Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Javier Perez-Rodriguez & Alejandro de la Fuente. (2017) Now is the Time for a Postracial Medicine: Biomedical Research, the National Institutes of Health, and the Perpetuation of Scientific Racism. The American Journal of Bioethics 17:9, pages 36-47.
Read now
Read now
Articles from other publishers (28)
Kenyon Railey, Mallory Mc Clester Brown & Anthony J. Viera. 2022. Family Medicine. Family Medicine
1043
1054
.
Kenyon Railey, Mallory Mc Clester Brown & Anthony J. Viera. 2020. Family Medicine. Family Medicine
1
12
.
Shawneequa L. CallierBrooke A. CunninghamJill PowellMary Anne McDonaldCharmaine D.M. Royal. (2019) Cardiologists' Perspectives on Race-Based Drug Labels and Prescribing Within the Context of Treating Heart Failure. Health Equity 3:1, pages 246-253.
Crossref
Crossref
Ping Li, Annise K. Chung, Samir S. Patel & Vasilios Papademetriou. 2019. Management of Hypertension. Management of Hypertension
145
154
.
Jessica L. Saben, Shelby K. Shelton, Andrew J. Hopkinson, Brandon J. Sonn, Eleanor B. Mills, Makayla Welham, Megan Westmoreland, Richard Zane, Adit A. Ginde, Kelly Bookman, Justin Oeth, Mark Chavez, Michael DeVivo, Alison Lakin, John Heldens, Laurie Blumberg Romero, Michael J. Ames, Emily R. Roberts, Matthew Taylor, Kristy Crooks, Stephen J. Wicks, Kathleen C. Barnes & Andrew A. Monte. (2018) The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care. Academic Emergency Medicine.
Crossref
Crossref
Nomsa Musemwa & Crystal A. Gadegbeku. (2017) Hypertension in African Americans. Current Cardiology Reports 19:12.
Crossref
Crossref
Theresa M. Beckie. (2017) Ethnic and racial disparities in hypertension management among women. Seminars in Perinatology 41:5, pages 278-286.
Crossref
Crossref
Keith C. Ferdinand & Samar A. Nasser. (2017) Management of Essential Hypertension. Cardiology Clinics 35:2, pages 231-246.
Crossref
Crossref
Elizabeth A. Jackson, Kristine Ruppert, Carol A. Derby, Yinjuan Lian, Genevieve Neal‐Perry, Laurel A. Habel, Ping G. Tepper, Siobán D. Harlow & Daniel H. Solomon. (2017) Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). Journal of the American Heart Association 6:3.
Crossref
Crossref
Nanette K. Wenger, Keith C. Ferdinand, C. Noel Bairey Merz, Mary Norine Walsh, Martha Gulati & Carl J. Pepine. (2016) Women, Hypertension, and the Systolic Blood Pressure Intervention Trial. The American Journal of Medicine 129:10, pages 1030-1036.
Crossref
Crossref
Fátima Rodriguez & Keith C. Ferdinand. (2015) Hypertension in Minority Populations: New Guidelines and Emerging Concepts. Advances in Chronic Kidney Disease 22:2, pages 145-153.
Crossref
Crossref
Luis M. Ortega, Emad Sedki & Ali Nayer. (2015) Hypertension in the African American population: A succinct look at its epidemiology, pathogenesis, and therapy. Nefrología (English Edition) 35:2, pages 139-145.
Crossref
Crossref
Luis M Ortega, Emad Sedki & Ali Nayer. (2015) Hypertension in the African American population: A succinct look at its epidemiology, pathogenesis, and therapy. Nefrología 35:2, pages 139-145.
Crossref
Crossref
John G. Kenerson. (2014) Hypertension in Haiti: The Challenge of Best Possible Practice. The Journal of Clinical Hypertension 16:2, pages 107-114.
Crossref
Crossref
Elizabeth O. Ofili, Dion H. Zappe, Das Purkayastha, Rita Samuel & James R. Sowers. (2013) Antihypertensive and Metabolic Effects of Angiotensin Receptor Blocker/Diuretic Combination Therapy in Obese, Hypertensive African American and White Patients. American Journal of Therapeutics 20:1, pages 2-12.
Crossref
Crossref
Basil N Okeahialam, Esther N Ohihoin & Jayne NA Ajuluchukwu. (2012) Diuretic drugs benefit patients with hypertension more with night-time dosing. Therapeutic Advances in Drug Safety 3:6, pages 273-278.
Crossref
Crossref
Steven G. Chrysant, Thomas LittlejohnIIIIII, Joseph L. IzzoJrJr, Dean J. Kereiakes, Suzanne Oparil, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2012) Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension. American Journal Cardiovascular Drugs 12:4, pages 233-243.
Crossref
Crossref
Steven G. Chrysant, Thomas LittlejohnIIIIII, Joseph L. IzzoJrJr, Dean J. Kereiakes, Suzanne Oparil, Michael Melino, James Lee, Victor Fernandez & Reinilde Heyrman. (2012) Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension. American Journal of Cardiovascular Drugs 12:4, pages 233-243.
Crossref
Crossref
Helga Gudmundsdottir, Aud Høieggen, Aud Stenehjem, Bård Waldum & Ingrid Os. (2012) Hypertension in women: latest findings and clinical implications. Therapeutic Advances in Chronic Disease 3:3, pages 137-146.
Crossref
Crossref
Keith C. Ferdinand & Raymond R. Townsend. (2012) Hypertension in the US Black Population: Risk Factors, Complications, and Potential Impact of Central Aortic Pressure on Effective Treatment. Cardiovascular Drugs and Therapy 26:2, pages 157-165.
Crossref
Crossref
Howard S Weintraub & Amy Rudolph. (2011) Combination Therapy for Managing Difficult-to-Treat Patients With Stage 2 Hypertension: Focus on Valsartan-Based Combinations. American Journal of Therapeutics 18:6, pages e227-e243.
Crossref
Crossref
Henry R. Black, Myron H. Weinberger, Das Purkayastha, Joleen Lee, Kanaka Sridharan, Marc Israel, Robert Hilkert & Joseph Izzo. (2011) Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension. The Journal of Clinical Hypertension 13:8, pages 571-581.
Crossref
Crossref
Elizabeth O. Ofili, Suzanne Oparil, Thomas Giles, Bertram Pitt, Das Purkayastha, Robert Hilkert, Rita Samuel & James R. Sowers. (2011) Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. Journal of the American Society of Hypertension 5:4, pages 249-258.
Crossref
Crossref
Keith C. Ferdinand, James Pool, Richard Weitzman, Das Purkayastha & Raymond Townsend. (2011) Peripheral and Central Blood Pressure Responses of Combination Aliskiren/Hydrochlorothiazide and Amlodipine Monotherapy in African American Patients With Stage 2 Hypertension: The ATLAAST Trial. The Journal of Clinical Hypertension 13:5, pages 366-375.
Crossref
Crossref
Jackson T. Wright Jr, Yves Lacourcière, Rita Samuel, Dion Zappe, Das Purkayastha & Henry R. Black. (2010) 24-Hour Ambulatory Blood Pressure Response to Combination Valsartan/Hydrochlorothiazide and Amlodipine/Hydrochlorothiazide in Stage 2 Hypertension by Ethnicity: The EVALUATE Study. The Journal of Clinical Hypertension 12:11, pages 833-840.
Crossref
Crossref
Keith C. Ferdinand. (2010) Management of High Blood Pressure in African Americans and the 2010 ISHIB Consensus Statement: Meeting an Unmet Need. The Journal of Clinical Hypertension 12:4, pages 237-239.
Crossref
Crossref
Bruce CreeEmmanuelle Waubant. (2010) Does race matter for multiple sclerosis?. Neurology 74:7, pages 532-533.
Crossref
Crossref
Barry J. Materson & Eileen M. Bernal. (2009) Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of hypertension. Journal of the American Society of Hypertension 3:5, pages 291-294.
Crossref
Crossref